Compare AN & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AN | KRYS |
|---|---|---|
| Founded | 1991 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5B | 6.3B |
| IPO Year | N/A | 2017 |
| Metric | AN | KRYS |
|---|---|---|
| Price | $216.03 | $256.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 9 |
| Target Price | ★ $237.90 | $234.33 |
| AVG Volume (30 Days) | ★ 372.1K | 288.2K |
| Earning Date | 02-10-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 275.72 |
| EPS | ★ 16.99 | 6.66 |
| Revenue | ★ $27,915,400,000.00 | $373,164,000.00 |
| Revenue This Year | $7.10 | $36.14 |
| Revenue Next Year | $2.56 | $41.80 |
| P/E Ratio | ★ $12.67 | $37.36 |
| Revenue Growth | 6.06 | ★ 54.51 |
| 52 Week Low | $148.33 | $122.80 |
| 52 Week High | $228.92 | $265.92 |
| Indicator | AN | KRYS |
|---|---|---|
| Relative Strength Index (RSI) | 59.68 | 72.43 |
| Support Level | $203.41 | $245.68 |
| Resistance Level | $214.35 | $257.95 |
| Average True Range (ATR) | 4.69 | 8.11 |
| MACD | 0.53 | -0.58 |
| Stochastic Oscillator | 84.40 | 100.00 |
AutoNation is the second-largest automotive dealer in the United States, with 2024 revenue of about $27 billion and over 240 dealerships, plus 52 collision centers. The firm also has 26 AutoNation USA used-vehicle stores, a captive lender, four auction sites, and three parts distributors across 20 states primarily in Sunbelt metropolitan areas. New-vehicle sales account for nearly half of revenue; the company also sells used vehicles, parts, and repair services as well as auto financing. The company (formerly Republic Industries) divested its waste management unit (Republic Services) in 1999 and its car rental businesses (ANC Rental) in 2000. Wayne Huizenga founded the company in the 1990s to bring the rollup acquisition strategy to auto retailing, which has proved to be a smart move.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.